DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver reiieneration in mice

被引:52
作者
Hanke, P
Serwe, M
Dombrowski, F
Sauerbruch, T
Caselmann, WH
机构
[1] Univ Bonn, Dept Med 1, D-53105 Bonn, Germany
[2] Univ Bonn, Inst Pathol, D-53105 Bonn, Germany
关键词
DNA vaccination; hepatocellular carcinoma; alpha-fetoprotein; liver regeneration;
D O I
10.1038/sj.cgt.7700445
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The oncofetal alpha - fetoprotein (AFP) is reexpressed in the majority of hepatocellular carcinomas and may be used as a target molecule for an immunotherapy or prophylaxis against this tumor. We investigated the potential of DNA vaccination with AFP-expressing plasmid DNA to induce an immune response against AFP-expressing tumor cells in DBA/2 mice. 62.5% of mice vaccinated with AFP-expressing plasmid DNA, rejected subcutaneous syngeneic AP-expressing P815 tumors, whereas only 16.7% of mice vaccinated with control plasmid rejected these tumor cells (P=.03). Mean survival of mice after challenge with subcutaneous AFP-expressing tumor cells was prolonged for 8 days in mice vaccinated with AR-expressing DNA (35 days) compared to mice vaccinated with control plasmid (27 days). To rule out possible autoimmune reactions against regenerating liver, which also reexpresses AFP, we evaluated the influence of AFP-specific DNA vaccination on liver regeneration in DBA/2 mice. Histologic quantification of proliferating hepatocytes and of the amount of necrotic liver tissue in carbon tetrachloride-damaged liver did not reveal statistically significant differences in mice vaccinated with AR-expressing plasmid compared to control mice. These data Suggest that AFP-specific DNA vaccination represents a useful tool to inhibit growth of AFP-expressing tumors in mice that does not affect liver regeneration.
引用
收藏
页码:346 / 355
页数:10
相关论文
共 44 条
[1]  
Bei R, 1999, CANCER RES, V59, P5471
[2]  
Bronte V, 2000, CANCER RES, V60, P253
[3]  
Butterfield LH, 1999, CANCER RES, V59, P3134
[4]  
Caselmann WH, 1999, Z GASTROENTEROL, V37, P353
[5]   Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16
[6]   Regulation and activities of alpha-fetoprotein [J].
Chen, HM ;
Egan, JO ;
Chiu, JF .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1997, 7 (1-2) :11-41
[7]   DNA-based immunization by in vivo transfection of dendritic cells [J].
Condon, C ;
Watkins, SC ;
Celluzzi, CM ;
Thompson, K ;
Falo, LD .
NATURE MEDICINE, 1996, 2 (10) :1122-1128
[8]  
CONRY RM, 1995, CANCER GENE THER, V2, P33
[9]   DIRECT GENE-TRANSFER INTO SKELETAL-MUSCLE INVIVO - FACTORS AFFECTING EFFICIENCY OF TRANSFER AND STABILITY OF EXPRESSION [J].
DAVIS, HL ;
WHALEN, RG ;
DEMENEIX, BA .
HUMAN GENE THERAPY, 1993, 4 (02) :151-159
[10]  
DEUTSCH HF, 1991, ADV CANCER RES, V56, P253